Givaudan SA Q2 2026 Earnings Recap

Shares fell 5.5% following results that disappointed investors due to margin compression and cautious outlook amid weak performance in Taste & Wellbeing. The decline reflects concerns over declining adjusted EPS and continued challenges in key markets despite some sequential improvement.

Key Takeaways

• Group sales rose 3.6% on a like-for-like basis but net income fell to CHF 475 million from CHF 592 million year-over-year.
• Adjusted EBITDA margin compressed to 24.3% from 25.2% in H1 2025, reflecting margin pressure despite solid volume growth.
• Taste & Wellbeing segment sales declined 6.3% in Swiss francs and showed only 0.5% like-for-like growth, highlighting ongoing market challenges.
• Fragrance & Beauty delivered mixed results with strong volume-led growth but weakness in Fragrance Ingredients and Active Beauty segments.
• Adjusted free cash flow was negative CHF 119 million in H1, impacted by higher investments and working capital timing, casting some doubt on cash generation near term.